Mutations or amplifications of RTK including EGFR, PDGFRA, basic fibroblast growth factor receptor 1 (FGFR-1), and insulin-like growth factor receptor (IGFR-1) are present in more than 80% of primary GBM [28]. The gene discussed is EGFR; the disease is glioblastoma.